Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120302
Status:
COMPLETED
Last Update Posted:
2008-01-17
First Post:
2005-07-08
Brief Title:
Quality of Life Study in Adults With Facial Eczema
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Quality of Life Study in Adults With Facial Eczema
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is not being conducted in the US
The study consists of a 4 week double blind treatment period All patients meeting the inclusionexclusion criteria will enter the study at day 0 and be randomized into either pimecrolimus cream 1 or vehicle treatment groups in a 11 ratio Patients will return to clinic on days 714 and 28 for assessments of disease severity Patients who experience an unsatisfactory therapeutic effect will attend an unscheduled visit and be withdrawn from the study
Assessments of eligibility include an Investigators Global Assessment and Pruritus score Treatment history will be collected at baseline and Quality of Life Questionnaires will be carried out at every visit
The study consists of a 4 week double blind treatment period All patients meeting the inclusionexclusion criteria will enter the study at day 0 and be randomized into either pimecrolimus cream 1 or vehicle treatment groups in a 11 ratio Patients will return to clinic on days 714 and 28 for assessments of disease severity Patients who experience an unsatisfactory therapeutic effect will attend an unscheduled visit and be withdrawn from the study
Assessments of eligibility include an Investigators Global Assessment and Pruritus score Treatment history will be collected at baseline and Quality of Life Questionnaires will be carried out at every visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None